Rongrong Xing

Title: Rongrong Xing: Innovator in Pharmaceutical Composition

Introduction

Rongrong Xing is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating ischemic diseases. His innovative approach combines traditional medicinal ingredients to enhance therapeutic efficacy.

Latest Patents

Rongrong Xing holds a patent for a pharmaceutical composition that includes salvianolic acid B and ginsenoside Rg1. The unique formulation boasts a weight ratio of 5 to (1-4.5) for the active ingredients. This composition demonstrates improved therapeutic efficacy in preventing and treating ischemic diseases and ischemia-reperfusion tissue or organ damage. The advancements in his patent provide a better active-ingredient proportion compared to prior art, making it a valuable contribution to medical science.

Career Highlights

Rongrong Xing is affiliated with the Chinese Academy of Sciences, where he conducts research and development in pharmaceutical sciences. His work focuses on innovative solutions to complex health issues, particularly those related to ischemic conditions. His dedication to research has led to significant advancements in the field.

Collaborations

Rongrong Xing collaborates with esteemed colleagues, including Baohong Jiang and Linlin Wang. Their combined expertise fosters a productive research environment, leading to groundbreaking discoveries in pharmaceutical applications.

Conclusion

Rongrong Xing's contributions to pharmaceutical innovation highlight the importance of combining traditional ingredients for modern medical applications. His work not only advances scientific knowledge but also offers hope for improved treatments for ischemic diseases.